| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.9M | +16.8% |
| Cost of Revenue | $7.0M | +11.5% |
| Gross Profit | $5.9M | +23.8% |
| R&D Expense | $22.5M | +0.0% |
| SG&A Expense | $17.5M | -13.7% |
| Operating Income | -$43.2M | +10.2% |
| Pre-tax Income | -$40.7M | +8.0% |
| Income Tax | $0 | — |
| Net Income | -$40.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $37.6M | -49.9% |
| Accounts Receivable | $6.0M | +86.8% |
| Inventory | $5.8M | -11.4% |
| Current Assets | $53.7M | -39.6% |
| Total Assets | $58.9M | -37.5% |
| Current Liabilities | $8.7M | -0.4% |
| Total Liabilities | $9.9M | +0.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$38.8M | +7.3% |
| Capital Expenditures | $383K | -52.4% |
| Investing Cash Flow | -$383K | +52.4% |
| Financing Cash Flow | $1.0M | +485.6% |
| Free Cash Flow | -$39.1M | +8.1% |
| +8.0% |
| EPS (Basic) | -$0.56 | +9.7% |
| EPS (Diluted) | -$0.56 | +9.7% |
| Stockholders' Equity |
| $49.0M |
| -41.9% |